ClinicalTrials.Veeva

Menu

Pneumoproteins Expression in the Organ Donor

U

University Hospital of Mont-Godinne

Status

Completed

Conditions

Primary Graft Dysfunction

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02032069
B406201112693

Details and patient eligibility

About

Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome. However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored. We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.

Enrollment

20 patients

Sex

All

Ages

5 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All the organ donors for lung grafts.

Exclusion criteria

none

Trial design

20 participants in 2 patient groups

NHBD
Description:
Non Heart Beating Donors
Treatment:
Other: no intervention
BDD
Description:
Brain death donors
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems